List of Studies ( Metabolite:PS 36:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003814 | AN006271 | Sulfur Amino Acid Restriction Enhances Exercise Capacity in Mice by Boosting Fat Oxidation in Muscle - extensor digitorum longus (EDL) versus soleus (Sol) on Con and SAAR diet lipidomics | Muscle | Mouse | Princeton University | LC-MS | |
| ST003785 | AN006220 | Sex differences in lipid profiles of visceral adipose tissue with obesity and gonadectomy | Tissue | Mouse | Obesity | University of Michigan | LC-MS |
| ST003747 | AN006153 | Phosphatidylinositol remodeling by lysophospholipid acyltransferase 11 ensures embryonic radial glial cell integrity - part 1 | Brain | Mouse | Brain disease | University of Tokyo | LC-MS |
| ST003661 | AN006018 | Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period | Blood | Human | Cardiovascular disease | Zhongshan Hospital Fudan University | LC-MS |
| ST003565 | AN005857 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003521 | AN005782 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | LC-MS |
| ST003291 | AN005390 | Atopic dermatitis and STAT3 double null mutant skin biopsies during healing. | Skin | Human | Eczema | National Institutes of Health | MALDI-MS |
| ST003184 | AN005229 | A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis - tumor lipidomics | Tumor cells | Mouse | Cancer | University of Colorado Anschutz Medical Campus | LC-MS |
| ST003179 | AN005221 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003160 | AN005184 | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003125 | AN005123 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Fetal liver | Liver | Mouse | Maternal immune system activation | University of Copenhagen | LC-MS |
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST003040 | AN004989 | MM.1S Myeloma tumor cells and tumors made by subcutaneously injecting 1M Luc+/GFP+ MM.1S cells treated with 50 μM BMS309403 and Vehicle (PBS with a matched concentration of 5% DMSO) | Cultured cells | Human | Cancer | Mainehealth | LC-MS |
| ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Blood | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Brain | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Spinal cord | Mouse | University of Kansas | LC-MS | |
| ST002926 | AN004798 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002782 | AN004529 | Lipidomics analysis of maternal obesity model - knock out | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002782 | AN004529 | Lipidomics analysis of maternal obesity model - knock out | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002452 | AN004008 | Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations | Brain | Human | Dementia | University of Sydney | LC-MS |
| ST002400 | AN003907 | Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis | Cultured cells | Human | INSERM | LC-MS | |
| ST002335 | AN003814 | Pathogenic Auxilin mutations affect lipids that are critical to Synaptojanin function | Insect tissue | Fruit fly | Parkinsons disease | VIB-KU Leuven | MS(Dir. Inf.) |
| ST002309 | AN003771 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002284 | AN003733 | Genetically defined human GBM organoids reveal principles of GBM development and actionable targets | Cultured cells | Human | Cancer | DKFZ | LC-MS |
| ST002057 | AN003349 | Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis | Cultured cells | Human | NASH | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001942 | AN003184 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001831 | AN002973 | Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort (part II) | Blood | Human | University of Michigan | LC-MS | |
| ST001820 | AN002954 | WT neurons treated with APOE3/3 and APOE4/4 ACM | Neurons | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001819 | AN002951 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mouse | Diabetes | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001795 | AN002916 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mesenteric lymph | Mouse | Obesity | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001789 | AN002901 | Acute metabolomic changes of plasma in response to endurance exercise | Blood | Human | University of California, San Diego | LC-MS | |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST001315 | AN002189 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001304 | AN002172 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | LC-MS |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001286 | AN002135 | Lipid composition of isolated lipid droplets from the functional bovine corpus luteum | Ovaries | Cow | University of Nebraska Medical Center | LC-MS | |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001272 | AN002112 | Growth cone memebrane and growth cone particulate lipidomics | Brain | Mouse | Eye disease | University of Miami | LC-MS |
| ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001111 | AN001806 | Breast Cancer Lipidomics Tissue | Adipose tissue | Human | Cancer | Baylor College of Medicine | LC-MS |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000880 | AN001436 | Diet, genetics and gut microbiome drive dynamic changes in plasma metabolites [cecal] | Blood | Mouse | Broad Institute of MIT and Harvard | LC-MS | |
| ST000823 | AN001308 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | Cyst fluid | Human | Cancer | University of Michigan | LC-MS |
| ST000617 | AN000946 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, San Diego | LC-MS |
| ST000450 | AN000706 | Metabolic features of chronic fatigue syndrome | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, San Diego | LC-MS |
| ST000414 | AN000655 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000136 | AN000218 | NIST lipidomics intralaboratory study | Blood | Human | University of Florida | LC-MS | |
| ST000114 | AN000193 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000110 | AN000184 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) | B-cells | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000076 | AN000121 | A549 Cell Study | Lung | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST000004 | AN000005 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | LC-MS |
